Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCARFREE-001: Intradermal Verteporfin for Scar Prevention
NCT07488988Phase 2Recruiting
- Sponsor
- University Hospital Odense
- Start
- Oct 2026
- Primary completion
- Aug 2028
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of verteporfin in surgical scar, sponsored by University Hospital Odense. Started Oct 2026; status: recruiting.
02
Drugs
verteporfin
03
Conditions
surgical scar
Beyond the preview
Go deeper on NCT07488988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07488988.